Communicare Inc

Communicare Inc - Elizabethtown, KY

Communicare Inc is a mental health and addiction treatment facility located at 100 Gray Street in the 42701 zip code in Elizabethtown, KY. It is operated by a private non-profit organization. Communicare Inc provides buprenorphine maintenance, administers naltrexone and relapse prevention from naltrexone. Some of the treatment approaches used by Communicare Inc include relapse prevention treatment, counseling for trauma victims and motivational interviewing. Communicare Inc provides 30 and 60 day inpatient rehab programs and long-term rehab. It also provides residential treatment for substance use and inpatient dual diagnosis treatment.

Call (888) 303-2026 to get 24/7 help with treatment.

WHO ANSWERS?

Address: 100 Gray Street, Elizabethtown, KY 42701

  1. Types of Care
  2. Service Settings
  3. Opioid Medications used in Treatment
  4. Type of Alcohol Use Disorder Treatment
  5. Type Of Treatment
  6. Pharmacotherapies
  7. Treatment Approaches
  8. Facility Ownership
  9. License/Certification/Accreditation
  10. Payment/Insurance/Funding Accepted
  11. Payment Assistance Available
  12. Special Programs/ Population Groups Supported
  13. Assessment/Pre-treatment
  14. Screening & Testing
  15. Transitional Services
  16. Ancillary Services
  17. Counseling Services and Education
  18. Tobacco/Screening Services
  19. Facility Smoking Policy
  20. Age Groups Accepted
  21. Gender Accepted
  22. Services for deaf

Here are the full facility listing details on Communicare Inc in Elizabethtown, KY:

Types of Care:

  • residential substance abuse treatment
  • inpatient treatment for dual diagnosis

Service Settings:

  • long term rehab
  • short-term residential treatment

Opioid Medications used in Treatment:

  • Buprenorphine clinical treatment
  • Naltrexone treatment

Type of Alcohol Use Disorder Treatment:

  • Administers medication for alcohol use disorder

Type Of Treatment:

  • buprenorphine maintenance
  • prescribes suboxone
  • naltrexone administration
  • relapse prevention from naltrexone

Pharmacotherapies:

  • Buprenorphine with naloxone (Ex. Suboxone)
  • Buprenorphine without naloxone
  • Naltrexone (oral)
  • Naltrexone (extended-release, injectable naltrexone - Vivitrol)

Treatment Approaches:

  • brief intervention
  • cognitive behavioral therapy
  • DBT
  • motivational interviewing
  • rational emotive behavioral therapy
  • relapse prevention treatment
  • counseling for substance abuse
  • trauma counseling
  • 12-step rehab

Facility Ownership:

  • a private non-profit organization

License/Certification/Accreditation:

  • State substance abuse agency

Payment/Insurance/Funding Accepted:

  • Accepts Federal funding
  • Accepts Medicaid
  • Accepts cash

Payment Assistance Available:

  • Sliding fee scale

Special Programs/ Population Groups Supported:

  • adult women
  • rehab for postpartum women

Assessment/Pre-treatment:

  • Comprehensive substance use assessment

Screening & Testing:

  • Breathalyzer or blood alcohol testing
  • Drug or alcohol urine screening
  • Screening for mental disorders
  • Screening for substance use
  • TB screening

Transitional Services:

  • Aftercare/continuing care
  • Discharge Planning

Ancillary Services:

  • housing services
  • self-help groups
  • group meetings

Counseling Services and Education:

  • individual counseling services
  • counseling for groups
  • family counseling
  • substance use education

Tobacco/Screening Services:

  • Screening for tobacco use
  • Smoking/tobacco cessation counseling

Facility Smoking Policy:

  • Smoking permitted in designated area

Age Groups Accepted:

  • adult rehab
  • accepts young adults over 18

Gender Accepted:

  • women

Services for deaf:

  • Service for hearing impaired

Phone #: 270-982-8824

Call (888) 303-2026 to get 24/7 help with treatment.

WHO ANSWERS?

What is dual diagnosis treatment?

Dual diagnosis treatment is a specialized approach to helping individuals who are dealing with both substance abuse issues and mental health disorders simultaneously. It recognizes the interconnected nature of these challenges and aims to address them comprehensively.

People with dual diagnosis face a unique set of hurdles as their mental health issues and substance use often reinforce each other, creating a cycle that can be difficult to break. For instance, someone with depression might turn to drugs or alcohol as a way to cope with their emotions, and the substance use can, in turn, exacerbate their mental health symptoms. This complex interaction requires a tailored treatment approach.

The primary goal of dual diagnosis treatment is to provide integrated care that addresses both the substance use disorder and the mental health condition concurrently. This involves a team of professionals, such as psychiatrists, psychologists, addiction specialists, and counselors, working collaboratively to develop a comprehensive treatment plan.

The treatment plan may include various therapeutic modalities, medication management, and support services. Cognitive-behavioral therapy (CBT), dialectical behavior therapy (DBT), and motivational interviewing are commonly used therapeutic approaches. Medications may be prescribed to manage psychiatric symptoms and support the individual's recovery from substance use.

Helpful resources: